XPO Schedules Fourth Quarter 2023 Earnings Conference Call for Wednesday, February 7, 2024
GREENWICH, Conn., Jan. 03, 2024 (GLOBE NEWSWIRE) — XPO (NYSE: XPO) will hold its fourth quarter conference call and webcast […]
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement BEDFORD, […]
Sun Communities, Inc. Announces Dates for Fourth Quarter 2023 Earnings Release and Conference Call
Southfield, MI, Jan. 03, 2024 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment trust […]
PennantPark Investment Corporation Announces Monthly Distribution of $0.07 per Share
MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for January […]
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) — PennantPark Floating Rate Capital Ltd. (the “Company”) (NYSE: PFLT) (TASE: PFLT) declares its […]
Keros Therapeutics Announces Proposed Public Offering of Common Stock
LEXINGTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on […]
Snail Games’ ARKade Ambassador Program Reshapes Gaming Connections
CULVER CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail” or “the Company”), a leading, global […]
QCR Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results
MOLINE, Ill., Jan. 03, 2024 (GLOBE NEWSWIRE) — QCR Holdings, Inc. (NASDAQ: QCRH) announced today that its fourth quarter and fiscal […]
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage […]
Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SEATTLE, Jan. 03, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for […]
